vitamin · for low mood
Vitamin D
Vitamin D receptors sit throughout the brain, including the regions that set mood.
Say that in clinical terms
Vitamin D receptors are expressed throughout the brain, including mood-regulating regions. Vitamin D modulates serotonin synthesis via tryptophan hydroxylase-2 activation and influences BDNF expression, neuroplasticity, and HPA axis regulation.
How strong is the research?
A 5-year trial in 18,353 adults found it did not reduce depression or lift mood.
2 papers read, 1 supporting, 1 against.
Who was studied: Earlier trials used people already depressed or badly deficient. The large VITAL trial in 18,353 adults did not.
How much to take
daily with a fat-containing meal
2000–4000 IU
Test 25(OH)D levels and aim for 40-60 ng/mL. Higher doses may be needed initially if deficient. Take with fat for absorption.
Before you take it
- NIH ODS Tolerable Upper Intake Level (UL) for adults aged 19+ is 4,000 IU/day
- Drug interaction: thiazide diuretics combined with vitamin D3 increase risk of hypercalcemia by reducing urinary calcium excretion
- Drug interaction: anticonvulsants (phenobarbital, phenytoin) induce CYP enzymes that accelerate vitamin D catabolism, reducing circulating levels and therapeutic efficacy
- Drug interaction: bile acid sequestrants (cholestyramine, colestipol) impair absorption of fat-soluble vitamins including vitamin D3; doses should be separated
- Drug interaction: orlistat inhibits dietary fat absorption and reduces vitamin D3 absorption; monitoring of vitamin D status is recommended with concurrent use
- Drug interaction: corticosteroids (e.g., prednisone, dexamethasone) impair vitamin D metabolism and reduce intestinal calcium absorption, potentially antagonizing vitamin D effects
- Drug interaction: vitamin D3 at high doses may alter CYP3A4 activity and potentially affect pharmacokinetics of statins metabolized by that pathway (atorvastatin, lovastatin, simvastatin); clinical significance is modest
- Contraindication: pre-existing hypercalcemia or hypercalciuria — supplementation without medical supervision is contraindicated
- Caution: granulomatous diseases (sarcoidosis, tuberculosis, histoplasmosis, some lymphomas) produce unregulated endogenous calcitriol independent of serum 25(OH)D; exogenous vitamin D supplementation can precipitate severe hypercalcemia — requires endocrinology oversight
- Caution: impaired renal function reduces conversion of vitamin D to active calcitriol and impairs urinary calcium excretion, increasing toxicity risk; monitoring is required
- Caution: primary hyperparathyroidism — calcium-vitamin D axis is dysregulated; supplementation requires specialist oversight
- Toxicity signs at sustained supra-UL doses: hypercalcemia, hypercalciuria, nausea, polyuria, weakness, nephrolithiasis, soft-tissue calcification, and irreversible renal damage
When to take it
Best taken: morning
What we make of it
The largest trial ever run, 18,353 people, found nothing — and it directly contradicts our source.
The detail
The VITAL trial followed 18,353 adults and found no effect on depression or mood. That directly contradicts the 2014 analysis we cite, which was single-authored and much weaker. When a trial that size finds nothing, it outweighs the earlier pooled work.